Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease
Nutrients · 28.10.2026 · 18 (21) · 3563
DOI: 10.3390/nu18213563 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 28.10.2026. Verfasst von Jiyeon Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Heart, Blood, and Kidney Research, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Amino Acids, Aromatic, Gastrointestinal Microbiome, Cardiovascular Diseases, Metabolic Diseases. Die Arbeit nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Cleveland Clinic, National Institutes of Health.
Abstract (Originalsprache)
The gut microbiota generates a diverse array of metabolites that influence host physiology. Among these, products of microbial metabolism of the aromatic amino acids tryptophan, phenylalanine, tyrosine, and histidine have emerged as important components of host-microbiome interactions relevant to cardiometabolic disease. This Review summarizes the microbial pathways, enzymes, and metabolic networks involved in aromatic amino acid metabolism and examines how dietary substrate availability, microbial community composition, microbial enzymatic capacity, host metabolism, and environmental factors influence metabolite production and biological activity. Microbiota-derived metabolites and host-microbial co-metabolites are associated with inflammation, vascular function, thrombosis, metabolic homeostasis, and host signaling pathways. Their biological effects are context-dependent and influenced by microbial pathway activity, host metabolic processing, tissue compartment, disease stage, and substrate availability. We further distinguish evidence derived from human observational studies, experimental metabolite administration, and demonstrated molecular mechanisms. Finally, we discuss strategies to modulate aromatic amino acid metabolism, including dietary interventions, functional foods, probiotics, fecal microbiota transplantation, microbial enzyme inhibitors, and metabolite sequestration approaches. Current evidence supports a framework linking dietary substrates, microbial enzyme activity, host responses, and cardiometabolic phenotypes, while highlighting important opportunities and challenges for developing precision microbiome-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Heart, Blood, and Kidney Research, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106, USA.
- Center for Microbiome & Human Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106, USA.
- Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
ORCID-Profile: Jiyeon Kim, Ina Nemet
Förderung
- NIH HHS
- Cleveland Clinic
- National Institutes of Health
Zitieren
APA
Kim, J., & Nemet, I. (2026). Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease. Nutrients, 18(21), 3563. https://doi.org/10.3390/nu18213563
Vancouver
Kim J, Nemet I. Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease. Nutrients. 2026;18(21):3563. doi:10.3390/nu18213563
BibTeX
@article{Kim2026,
author = {Kim, Jiyeon and Nemet, Ina},
title = {Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {21},
pages = {3563},
doi = {10.3390/nu18213563}
}
EUVIMED